TABLE 2.
Plasma visfatin (ng/ml) | P* | CSF visfatin (ng/ml) | P* | |
---|---|---|---|---|
Body fat quartile | ||||
1 | 24.87 ± 0.96 | 0.001 | 4.22 ± 0.18† | 0.0001 |
2 | 28.58 ± 2.17 | 0.001 | 3.55 ± 0.57 | 0.003 |
3 | 29.92 ± 2.28 | 0.01 | 3.27 ± 0.19 | NS |
4 | 49.71 ± 6.81 | 2.66 ± 0.14 | ||
Body weight status | ||||
Normal weight | 26.43 ± 1.58 | 0.002 | 3.81 ± 0.24‡ | 0.005 |
Overweight | 29.45 ± 1.75 | 0.004 | 3.32 ± 0.14 | NS |
Obese | 49.37 ± 6.86 | 2.98 ± 0.20 | ||
Sex | ||||
Male | 35.56 ± 4.19 | 3.50 ± 0.16 | ||
Female | 31.79 ± 2.89 | 3.33 ± 0.19 |
Data are means ± SEM. n = 38: 18 men and 20 women; 14 normal-weight subjects, 14 overweight subjects (BMI 25 to <30 kg/m2), and 10 obese subjects (BMI ≥30 kg/m2). Differences between men and women were not significant.
For comparisons with body fat quartile 4 and obesity, respectively.
P = 0.015 and 0.002 for comparison with body fat quartiles 2 and 3, respectively.
P = 0.03 for comparison with overweight.